AccScience Publishing / JCBP / Online First / DOI: 10.36922/JCBP026030003
REVIEW ARTICLE

Expert consensus on the clinical application of Tianmeng oral liquid in psychosomatic disorders

Zhenghua Hou1 Leyi Zhang2 Sizhi Ai3 Maosheng Fang4 Rongjuan Guo5 Manli Huang6 Wenjing Jiang7 Xiuli Li8 Jin Liu9 Ping Liu10 Xiangzhe Liu11 Dongsheng Lv12 Lijun Qiao13 Qinji Su14 Lu Sun15 Jiong Tao16 Jing Teng17 Han Wang18 Chuansheng Wang19 Huaning Wang20 Peng Xiong21 Fengquan Xu22 Zhenghui Yi4 Jie Zhang23 Yupeng Zhang24 Min Zhao11 Peng Zhao25 Yuehan Zhao26 Bo Zhou27 Shaohong Zou28 Wei Zou29 Wenbin Guo2* Yonggui Yuan1*
Show Less
1 Department of Psychosomatic Medicine, Zhongda Hospital, Southeast University, Nanjing, Jiangsu, China
2 Department of Psychiatry, National Clinical Research Center for Mental Disorders, and National Center for Mental Disorders, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China
3 Centre for Sleep and Circadian Medicine, The Affiliated Brain Hospital, Guangzhou Medical University, Guangzhou, Guangdong, Chin
4 Clinical Department 7, Shanghai Mental Health Center, Shanghai, China
5 Department of Psychosomatic Medicine, Dongfang Hospital, Beijing University of Chinese Medicine, Beijing, China
6 Department of Psychiatry, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China
7 Department of Geriatric Medicine, Qilu Hospital of Shandong University, Jinan, Shandong, China
8 Department of Clinical Psychology, Yidu Central Hospital, Weifang, Shandong, China
9 Department of Neurology, Tianjin Prevention and Treatment Center for Occupational Diseases, Tianjin, China
10 Department of Cardiology, The Qilu Second Hospital of Shandong University, Jinan, Shandong, China
11 Department of Encephalopathy, The First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou, Henan, China
12 Department of Psychiatry, Inner Mongolia Autonomous Region Brain Hospital (Mental Health Center), Inner Mongolia, China
13 Department of Neurology, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China
14 Department of Mental Health, The Second Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China
15 Department of Psychosomatic Diseases, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China
16 Department of Psychiatry, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China
17 Department of Neurology, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, Shandong, China
18 Encephalopathy Center, The First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei, Anhui, China
19 Department of Psychiatry, The Second Affiliated Hospital of Henan Medicine University, Zhengzhou, Henan, China
20 Department of Psychosomatic Medicine, Xijing Hospital, Xi’an, Shaanxi, China
21 Department of Psychiatry, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China
22 Department of Psychosomatic Medicine, Guang’anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China
23 Department of Psychosomatic Medicine, Beijing Hospital of Traditional Chinese Medicine affiliated to Capital Medical University, Beijing, China
24 Department of Clinical Psychology, Changchun Sixth Hospital, Changchun, Jilin, China
25 Department of Cardiology, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China
26 Department of Clinical Psychology, Weifang People’s Hospital, Weifang, Shandong, China
27 Sichuan Provincial Center for Mental Health, Sichuan Provincial People’s Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, Sichuan, China
28 Department of Clinical Psychology, People’s Hospital of Xinjiang Uygur Autonomous Region, Urumqi, Xinjiang, China
29 Department of Acupuncture and Moxibustion, The First Affiliated Hospital of Heilongjiang University of Chinese Medicine, Harbin, Heilongjiang, China
Received: 14 January 2026 | Revised: 30 January 2026 | Accepted: 13 February 2026 | Published online: 31 March 2026
© 2026 by the Author(s). This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution 4.0 International License ( https://creativecommons.org/licenses/by/4.0/ )
Abstract

Psychosomatic disorders are characterized by complex interactions between psychological factors and somatic symptoms and frequently present with comorbid insomnia, anxiety, and depressive symptoms. Although conventional pharmacological treatments are widely used, their limitations highlight the need for integrative therapeutic approaches. Tianmeng oral liquid, a multi-component Chinese herbal formulation, has been increasingly used in clinical practice for the treatment of psychosomatic symptoms. This review aims to develop expert consensus on the clinical application of Tianmeng oral liquid in the treatment of psychosomatic disorders. This consensus was developed through a comprehensive review of the literature, evaluation of available clinical and experimental evidence, and structured expert panel discussions. Recommendations were formulated based on evidence strength, clinical experience, and principles of psychosomatic medicine. Tianmeng oral liquid exhibits a multi-target pharmacological profile, modulating central nervous system activity, neuroendocrine regulation, and immune homeostasis. Available evidence suggests that it may improve sleep quality, alleviate anxiety and depressive symptoms, and enhance overall well-being in patients with psychosomatic disorders. The formulation may be used as monotherapy in mild cases or as an adjunct to standard pharmacological and psychological interventions. It is generally well tolerated when administered according to recommended dosing strategies. Tianmeng oral liquid may be considered a complementary therapeutic option within a comprehensive biopsychosocial treatment framework for psychosomatic disorders. Further high-quality randomized controlled trials and mechanistic studies are warranted to strengthen the evidence base and refine clinical application strategies.

Keywords
Psychosomatic disorders
Insomnia
Tianmeng oral liquid
Integrative medicine
Chinese herbal compound
Funding
None.
Conflict of interest
Bo Zhou, Shaohong Zou, and Wenbin Guo are the Editorial Board Members of this journal, but were not in any way involved in the editorial and peer-review process conducted for this paper, directly or indirectly. Separately, other authors declared that they have no known competing financial interests or personal relationships that could have influenced the work reported in this paper.
References
  1. Jantschek G, Rodewig K, Von Wietersheim J, et al. Concepts of psychosomatic disorders in ICD-10: results of the Research Criteria Study. Psychother Psychosom. 1995;63(2):112-123. doi: 10.1159/000288947

 

  1. Kellner R. Psychosomatic syndromes, somatization and somatoform disorders. Psychother Psychosom. 1994; 61(1-2):4-24. doi: 10.1159/000288868

 

  1. Fava GA, Cosci F, Sonino N. Current Psychosomatic Practice. Psychother Psychosom. 2017;86(1):13-30. doi: 10.1159/000448856

 

  1. Lask B. “Psychosomatic medicine” not “psychosomatic disorders”. J Psychosom Res. 1996;40(5):457-460. doi: 10.1016/0022-3999(95)00578-1

 

  1. Chandrashekar CR, Math SB. Psychosomatic disorders in developing countries: current issues and future challenges. Curr Opin Psychiatry. 2006;19(2):201-206. doi: 10.1097/01.yco.0000214349.46411.6a

 

  1. Ma N, Pan B, Yang S, et al. Comparative efficacy and safety of Chinese patent medicines for primary insomnia: A systematic review and network meta-analysis of 109 randomized trials. J Ethnopharmacol. 2025;340:119254. doi: 10.1016/j.jep.2024.119254

 

  1. Fava G A, Sonino N. Psychosomatic assessment. Psychother Psychosom. 2009;78(6):333-41. doi: 10.1159/000235736

 

  1. Spitzer RL, Kroenke K, Williams JB. Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire. JAMA. 1999;282(18):1737-1744. doi: 10.1001/jama.282.18.1737

 

  1. Lowe B, Decker O, Muller S, et al. Validation and standardization of the Generalized Anxiety Disorder Screener (GAD-7) in the general population. Med Care. 2008;46(3):266-274. doi: 10.1097/MLR.0b013e318160d093

 

  1. Kroenke K, Spitzer R L, Williams J B. The PHQ-15: validity of a new measure for evaluating the severity of somatic symptoms. Psychosom Med. 2002;64(2):258-66. doi: 10.1097/00006842-200203000-00008

 

  1. Li L, Peng T, Liu R, et al. Development of the psychosomatic symptom scale (PSSS) and assessment of its reliability and validity in general hospital patients in China. Gen Hosp Psychiatry. 2020;64:1-8. doi: 10.1016/j.genhosppsych.2020.01.008

 

  1. Liu XY. Establishment of Fingerprint of Tianmeng Oral Liquid and Efficacy-related Components Study. [Dissertation] Shandong University. 2020. [In Chinese] doi: 10.27272/d.cnki.gshdu.2020.005146

 

  1. Zhang DX, Sun WX, Shi HB, et al. Meta-analysis and GRADE evaluation of Tianmeng capsule(oral liquid)in the treatment of sleep disorders. Clin Res Pract. 2025;10(01):1-7. [In Chinese] doi: 10.19347/j.cnki.2096-1413.202501001

 

  1. Tong JY. Clinical observation of sweet dream oral liquid combined with Oxazepam in treating insomnia. China’s Naturop. 2019;27(17):72-74. [In Chinese] doi: 10.19621/j.cnki.11-3555/r.2019.1738

 

  1. Wang XY. Observation on the Therapeutic Effect of Tianmeng Oral Liquid in Patients with Insomnia. Chin J Mod Drug Appl. 2016;5:165-166. [In Chinese]. Available from: http://dianda.cqvip.com/Qikan/Article/Detail?id=667910667&from=Qikan_Article_Detail [Last accessed on 2016 Mar 09].

 

  1. Yao MM, Zhang YR. Efficacy and safety of Tianmeng oral liquid in the treatment of insomnia: a meta-analysis. Hainan Med j. 2021;32(21):2824-2830. [In Chinese]. Available from: https://oversea.cnki.net/kcms2/article/abstract?v=zO3wb1M9ekztpCgosv8OiQOsq9SZspuCKmx_5mDPsB_CosIgk_ipbse6kDnuck3JA-R5hzpfeZfWlSmhrumBCs23u_Vx3OL830sOv5PkTLTiyM3URcXapud0KEi5N4KawarLxlnFKyFJ_Gld_x-ZqMcl4HwsR_b5QKw2IOco21DzpeRbo8HarQ==&uniplatform=OVERSEA [Last accessed on 2021 Nov 15].

 

  1. Yang S, Yu F, Xiang X, et al. Cost-effectiveness analysis of commercial Chinese polyherbal preparations for primary insomnia: based on network meta-analysis. Front Pharmacol. 2025;16:1682173. doi: 10.3389/fphar.2025.1682173

 

  1. Lin H, Yu ZF, Chen HH, et al. Clinical study on Tianmeng Oral Liquid in treatment of hyperprolactinemia caused by risperidone in female schizophrenia. Chin Tradit Herb Drugs. 2018;49(22):5373-5377. [In Chinese]. Available from: https://oversea.cnki.net/kcms2/article/abstract?v=zO3wb1M9ekyvaEUTJsm5LBb6UD02tX-dCiHdiVPF9i69CXeAAk_bJoB0UEHSnklKW133xIUGQb6HqSWgXhhMvskuDhFyavj_BQTybaOJsWg4O-BhNL1itIbSx69Ec3IKck6RJMIJpgts0xAfMJiIF3SR_UhHUy0IRibOVyqOLGbPt_z9MdRc_w==&uniplatform=OVERSEA [Last accessed on 2018 Dec 19].

 

  1. Jin FB, Hou RT, Li GF, et al. Clinical Observation of Tianmeng Oral Liquid in the Treatment of Diabetes with Comorbid Depression. Chin Tradit Herb Drugs. 2007;06:905-906. [In Chinese] doi: 10.3321/j.issn:0253-2670.2007.06.045

 

  1. Zhao J, Su MX, Fang QX. Clinical observation of Tianmeng Oral Liquid in treatment of chronic obstructive pulmonary disease and insomnia. Chin Tradit Herb Drugs. 2017;48(17):3587-3589. [In Chinese]. https://oversea.cnki.net/kcms2/article/abstract?v=zO3wb1M9ekweUhLFzty3GFQazCiqkGmYmYNG1wEM9W2DQiYgsZMSfKPCBUvrbrZfFfQRxLgtEhWNmZqPo0Z3UYUkdumi2Q4OBc1vD_MSVdBl9tIx6PZUfBCWcix-9EHt8priFS8eHy_4MfBYMW-0riFT45qLDNEd3iOz-EeUQummvHJPxO-FXA==&uniplatform=OVERSEA [Last accessed on 2017 Sep 26].

 

  1. Luo JH, Li DG. Influence of sweet dream oral early intervention on depression and neurological rehabilitation after stroke. Chin Mod Med. 2014;21(03): 47-48. [In Chinese]. Available from: https://oversea.cnki.net/kcms2/article/abstract?v=OGEEvuKkrhb2EFaL2kl8KhcF_VwwhAMBbFb44x4CgdtNZx8IJafQGbPlvZ7wyliwGf87Nt1FFxILrAX38oJeghfkPpRc83vVdaSTQIjRQWyvBoJWvniV3kYfL1mZT_x5YgQUA0j9kfUcvOoR3NtAOmmCNBYB-cv9PGCmQur-YhLFgbRavno7Yw==&uniplatform=OVERSEA&language=EN [Last accessed on 2014 May 22].

 

  1. Sun ML, Yang XC, Zhang SY, Zeng CY, Huang LX. Effect of Tianmeng Oral Liquid Combined with Zolpidem Tablets on Sleep Quality and Quality of Life in Patients with Gynecological Malignancies Undergoing Postoperative Chemotherapy. Strait Pharm J. 2020;32(11):148-150. [In Chinese]

 

  1. Bai R R. Clinical observation of Tianmeng Oral Solution combined with zopiclone in treatment of senile cor pulmonale insomnia. Drugs Clin. 2016;31(09):1468-1472. [In Chinese]. Available online: https://oversea.cnki.net/kcms2/article/abstract?v=zO3wb1M9ekwyhzzyOBRZ3z5nLxsWBVLKbH1RnFlVA0LEnJtZlBALe9VhjO28NT89aQMF97hRkrC_Jmwzyw7FVpotFInaUYkCcg9iLkQkro orWBXUsBEDMFWdTvjGkvYQyLqkEIRyakaOuk6dN0nyVByJpxF49tKYsdr_vDm_ynBsSqZXD7dhQ==&uniplatform=OVERSEA [Last accessed on 2016 Sep 22].

 

  1. Gu JH, Zhang HM. Observation on the Curative Effect of Acupuncture on Sishengcong Combined with Tianmeng Oral Liquid in the Treatment of Senile Insomnia. World of Sleep Med. 2018;5(11):1296-1297. [In Chinese]. Available from: https://oversea.cnki.net/kcms2/article/abstract?v=zO3wb1M9ekzmyulzVbQc_H13BJmQbECscxyNpb1cci35w7VIR-YMm9bYk8UJGm-O1g2FdQnkm0esB2RLNB6dGDedhRwWgDlnvk1ZYrvtHH_PP-EhMvFX8568aL_uree-V692ea8jXD9QJZBq05g2WEad8J0LTeIiojS48Hc3pP35ATTIYUdfw==&uniplatform=OVERSEA [Last accessed on 2018 Dec 26].

 

  1. Xiao D F. Clinical observation of Tianmeng Oral Liquid combined with eszopiclone in treatment of post-stroke insomnia. Drugs Clin. 2016;31(10):1612-5. [In Chinese]. Available from: https://oversea.cnki.net/kcms2/article/abstract?v=zO3wb1M9ekwN-kWeaQywPgRCX2zRfiV86Ym_53UAl3KmqlgbDkcHf4PmkQM1uk4VN-n5V3z-NCHnFGnjTRL3XffKdNkdP2TJ0mlyUnEhrtBIske0fuXjQq7KTxJA8RdhO7Kfc9c4MfyR9nCVXjLyksUxPD5Smasi4sJ_uCgBVW49NekxeXubcQ==&uniplatform=OVERSEA [Last accessed on 2016 Nov 03].

 

  1. Huang WZ, Xie TS, Luo ZD, et al. Clinical Efficacy of Eszopiclone Combined with Tianmeng Oral Liquid in Treating Sleep Disorders in Patients with Mild Stroke. J Qiqihar Med Univ. 2019;40(12):1471-1472. [In Chinese] doi: 10.3969/j.issn.1002-1256.2019.12.008

 

  1. Wang CY, Wang YJ, Zeng H, et al. Effects of flupentixol and melitracen tablets combined with Tianmeng Oral Liquid on sleep quality and negative emotions of insomnia patients with anxiety. J Clin Med Pract. 2020;24(09):33-36. [In Chinese]. Available from: https://oversea.cnki.net/kcms2/article/abstract?v=zO3wb1M9ekyfSYDuDKZ_PNC5De2--mDLY_Habfb-fI-GC8ew6XsiulOyq1lwHxE1mPSIDy-QFVKrzsQHwPY5FypWOKVLse1Hvo8LostOrahrCtyTUWhdy5Xtn8jMKgOKSGfIm9U3uhxokiERJTkuSx7vg2OJz5sFdlAuiThuXdRVoP9p_-v0dQ==&uniplatform=OVERSEA [Last accessed on 2020 Jun 17].

 

  1. Wang ZY, Sun YZ, Shi YH, et al. Network Meta-analysis of Chinese patent medicine for post-stroke depression. Drug Eval Res. 2021;44(12):2664-2680. [In Chinese]. Available from: https://oversea.cnki.net/kcms2/article/abstract?v=zO3wb1M9ekzSfBZ4_QD4Qd__cUBUbWQ__HGuh5UMaJJ8vNrH80cFopzGEo-x7haH2qKMxD7sbVIWI6iYC85J4WXCbbMvRHQkaAjo2x7pn5KeUsIogSs6Z7YrIekyDWJU-MIsuSGA1cAiqaMJk6kcE0qVijworQPv373gkXmlLyrN6mLhbOrBDg==&uniplatform=OVERSEA [Last accessed on 2021 Dec 07].

 

  1. Xia SB, Yu DH. Clinical Observation of Tianmeng Oral Liquid Combined with Paroxetine in the Treatment of Perimenopausal Depression. Chin Pharm. 2017;28(03):344-347. [In Chinese]. Available from: https://oversea.cnki.net/kcms2/article/abstract?v=zO3wb1M9ekzSfBZ4_QD4Qd__cUBUbWQ__HGuh5UMaJJ8vNrH80cFopzGEo-x7haH2qKMxD7sbVIWI6iYC85J4WXCbbMvRHQkaAjo2x7pn5KeUsIogSs6Z7YrIekyDWJU-MIsuSGA1cAiqaMJk6kcE0qVijworQPv373gkXmlLyrN6mLhbOrBDg==&uniplatform=OVERSEA [Last accessed on 2017 Feb 16].

 

  1. Wang SX, Pang YC, Wang DK, et al. Clinical Observation of Tianmeng Oral Liquid Combined with Paroxetine in the Treatment of Post-Traumatic Depression. Chin Tradit Herb Drugs. 2006;08:1227-1228. [In Chinese] doi: 10.3321/j.issn:0253-2670.2006.08.045

 

  1. Wang Q, Bai LD, Zhang M, et al. Effect of Tianmeng oral liquid combined with atypical antipsychotic drugs on serum prolactin and sex hormone in patients with schizophrenia. Chin Med. 2018;13(06):870-874. [In Chinese]. Available from: https://oversea.cnki.net/kcms2/article/abstract?v=zO3wb1M9ekyE41kGsz9cnx_BdGi_3rjPx98J1NKQCPxghril0LQV5swRBPj-rDbHQ1lMt1PXoMVkW8-i3PBKFUSyuExY1hQi-QuKG9_C46Xcqn6wze2EZhmkxp7tnOgSQNHN5zkKoQZ6vRS8bMiALIPfnP0GhSIOnSESTq9-QAEx8V8CeBSAg==&uniplatform=OVERSEA [Last accessed on 2019 Apr 03].

 

  1. Lan XJ, Qin ZJ, Liu QM, et al. Efficacy and safety of Tianmeng Oral Liquid in the treatment of hyperprolactinemia caused by antipsychotics in female patients with schizophrenia: a Meta-analysis. Sichuan Ment Health. 2023;36(01):25-31. [In Chinese]. Available from: https://oversea.cnki.net/kcms2/article/abstract?v=zO3wb1M9ekweFTFN0zB9HXcYHwJUckzzUy2AUc1sPfZbasGZvvJ7D7L4WM1yhRdyMCfa87CoEkcZ1cgaIOyQDz9-kQcCNqeZhHQECel_fvd5XvF2GXSPamsHGwwl2pObUyHNPFRddq14vlh-LKsxVFvwAucVA16F8yqGi0D1z4WHzbrfo68Bg==&uniplatform=OVERSEA [Last accessed on 2023 Mar 15].

 

  1. Liu J. Observation on the Efficacy of Tianmeng Oral Liquid in Regulating Autonomic Nervous System Imbalance. Chin Tradit Herb Drugs. 2010;41(07):1157-1158. [In Chinese]. Available from: https://d.wanfangdata.com.cn/periodical/CiBQZXJpb2RpY2FsQ0hJU29scjkyMDI2MDMwNjE2NTI1NxIMemN5MjAxMDA3MDM1GghscTR2Zms4MQ%3D%3D [Last accessed on 2010 Sep 13].

 

  1. Li CL, Xu Y, Jiang J, et al. Effects of Tianmeng Oral Liquid on Learning and Memory, Inflammatory Factors, and Neurotransmitters in Sleep-Deprived Rats. Pharmacol Clin Chin Mater Medica. 2015;31(02):147-148. (In Chinese). Available from: https://d.wanfangdata.com.cn/periodical/CiBQZXJpb2RpY2FsQ0hJU29scjkyMDI2MDMwNjE2NTI1NxIQenl5bHlsYzIwMTUwMjA2NRoIMWwxdGZnMzI%3D [Last accessed on 2010 Sep 13].

 

  1. Su X, Wang C, Wang X, Han F, Lv C, Zhang X. Sweet Dream Liquid Chinese Medicine Ameliorates Learning and Memory Deficit in a Rat Model of Paradoxical Sleep Deprivation through the ERK/CREB Signaling Pathway. J Med Food. 2016;19(5):472-480. doi: 10.1089/jmf.2015.3530

 

  1. Liu K, Xia Q R, Liang J, et al. Effect and mechanism of Tianmeng oral liquid on glucose and lipid metabolism and endocrine disorders induced by risperidone. Cent South Pharm. 2024;22(11):2937-2942. [In Chinese]. Available from: https://oversea.cnki.net/kcms2/article/abstract?v=zO3wb1M9ekwDTtbIihwziTZbkwzPDtUgOtX9OD5OwKl8Da25_1WpATzz0wDPeYgCAGNK_Q8R812Gxzk1BlTHTBY8f2gG5irGGtJ2ZA8MrcNkfBFTTpRmwR_sidma_dre1AE0tHlvNXTUBG2J9Y81iQEcAKptQTDWgwM02TwGBWjnV7S2FZEUIw==&uniplatform=OVERSEA [Last accessed on 2018 May 23].

 

  1. Han GJ. Study on the Improvement of Prolactin Levels and Cognitive Function in Schizophrenia Patients with Hyperprolactinemia by Different Treatments. 2024. [In Chinese] doi: 10.26921/d.cnki.ganyu.2024.000696

 

  1. Zhang YJ, Zhang J. Therapeutic effect of Tianmeng oral liquid combined with cystine tablet in the treatment of 52 cases of male-pattem alopecia. Clin Res Pract. 2018;3(22):138-140. doi: 10.19347/j.cnki.2096-1413.201822064 (In Chinese)

 

  1. Ding WT. Clinical Observation of Tianmeng Oral Liquid in the Treatment of Insomnia with Erectile Dysfunction. Chin Med Herald. 2007;20:106. [In Chinese] doi: 10.3969/j.issn.1673-7210.2007.20.081

 

  1. Zhang Y, Ji QL. Effect of sweet dream oral liquid combined with Doxepin in the treatment of palmoplantar eczema in patients with anxiety. Chin Pract Med. 2020;15(26):109-111. [In Chinese] doi: 10.14163/j.cnki.11-5547/r.2020.26.046

 

  1. Liu X, Zhang AJ, Yan ZR. Improvement of Post-Stroke Depression, Sleep, or Cognitive Dysfunction by Mindfulness Therapy Combined with Tianmeng Oral Liquid. Medical Diet and Health. 2020;18(04):55-56. [In Chinese]. Available from: https://d.wanfangdata.com.cn/periodical/CiBQZXJpb2RpY2FsQ0hJU29scjkyMDI2MDMwNjE2NTI1NxIQeXhzbHlqazIwMjAwNDAzORoIa3J4eWx1dDg%3D [Last accessed on 2020 Apr 28].

 

  1. Wu D, Guo RJ, Wang Y. Clinical observation of Sweet Dream Oral Liquid curing deficiency of spleen and kidney style MCI. Chin Tradit Herb Drugs. 2017;48(23):4958-4962. [In Chinese]. Available from: https://oversea.cnki.net/kcms2/article/abstract?v=zO3wb1M9ekySbio4UygghbmRHqV9tG_BVonlGqhMCho4GStUTN1xaoTsMx-hZg64zxDOJB7y8csCS59yIhIrP6fVvSFkPawZcJll85FfaG84EmvLvBeb79cNxtZeJmbs_rBT6pHLl_MnsuJJ2Yq9JzifoOz9FyJyO-vGZoV8pUxXtaGDl6afsA==&uniplatform=OVERSEA [Last accessed on 2018 Jan 05].

 

  1. Dai BX, Yuan CR. Clinical Effective observation on Neurasthenia Treated by Tian Meng Oral Fluid. J Guiyang Univ Chin Med. 2003;(02):14-15. [In Chinese] doi: 10.3969/j.issn.1002-1108.2003.02.009

 

  1. Expert Group on Clinical Application of Tianmeng Oral Liquid (Capsules). Expert Recommendations on the Clinical Application of Tianmeng Oral Liquid (Capsules). J Psychiatry. 2019;32(4):294-298. [In Chinese] doi: 10.3969/j.issn.2095-9346.2019.04.015

 

  1. Shi J. Guidelines for Clinical Application of Chinese Patent Medicine in Treatment of Insomnia (2023). Chin J Integr Tradit West Med. 2025;1-8. [In Chinese]

 

  1. Alimoradi Z, Jafari E, Brostrom A, et al. Effects of cognitive behavioral therapy for insomnia (CBT-I) on quality of life: A systematic review and meta-analysis. Sleep Med Rev. 2022;64:101646. doi: 10.1016/j.smrv.2022.101646

 

  1. Wang JM, Nie CM, Zhang Y. Clinical Efficacy of Cognitive Behavior Therapy Plus Tianmeng Oral Liquid in Treatment of Insomnia. World J Sleep Med. 2020;7(03):441-443. [In Chinese]. Available from: https://oversea.cnki.net/kcms2/article/abstract?v=zO3wb1M9ekwTlCOFCYNtCOxgC7VA1QDCzpoY5J36v0slZOwBJYDbEnSKORkBRLtxeLuIhEMm4smJququUdyJaQeAJk64FXlfFCl8bFhHoSZdYl2aGN1lp6HfH1kY81LIdHVSyl-i_P3MBFi72KwUP3MxYMJ7czpUD8x9hRMJfOAYHg aj4WQYwQ==&uniplatform=OVERSEA [Last accessed on 2020 May 28].

 

  1. Li Z, Hao GJ, Li GY, et al. Observation on Curative Effect of Tianmeng Oral Liquid Combined with Psychotherapy on Insomnia. World J Sleep Med. 2018;5(04):433-435. [In Chinese]. Available from: https://oversea.cnki.net/kcms2/article/abstract?v=zO3wb1M9ekxk9q1QZoACL3xKGS07qshY79GO8Jdas1z4kvSTE83zaNZAnVjJ1FGawWeLKcTx7PJXQN2DfSj5EgTSi7Q4mNzd7Rlu4H5Hi7-HDnBbi81xzhgd5Y1JuTmaVNoYiu-_ _y_99bRy0g47j5xs6gMLPp_z_KJKQztEDb7ZlgAOK8wsVFw==&uniplatform=OVERSEA [Last accessed on].

 

  1. Gong YR, Tang L. Progress in physical therapy of sleep disorders. China Modern Medicine. 2023;30(10): 48-53. [In Chinese]. Available from: https://oversea.cnki.net/kcms2/article/abstract?v=zO3wb1M9ekyK8JiwRZk0oy5tCsGa0acdZelt3QnwmlZ_PM3DSy7lqOONutNazHkX0MNl8AMOe7IrUwmd5-lS3joloM6dV144nsut2KKX91D8t0V4DHMkT1kP5ZahRM4seFyYOA5o8WAesDMRMMbEZjLMkmi1ufTYu1eJ8UsLpd6eS80Jh1-ORQ==&uniplatform=OVERSEA [Last accessed on 2023 May 11].

 

  1. Guo YX. Clinical Observation of Tianmeng Oral Liquid Combined with Repetitive Transcranial Magnetic Stimulation in Elderly Patients with Insomnia. Chin Naturop. 2018;26(03):51-53. [In Chinese] doi: 10.19621/j.cnki.11-3555/r.2018.0336

 

  1. Goessl VC, Curtiss JE, Hofmann SG. The effect of heart rate variability biofeedback training on stress and anxiety: a meta-analysis. Psychol Med. 2017;47(15):2578-2586. doi: 10.1017/S0033291717001003

 

  1. Lin IM, Fan SY, Yen CF, et al. Heart Rate Variability Biofeedback Increased Autonomic Activation and Improved Symptoms of Depression and Insomnia among Patients with Major Depression Disorder. Clin Psychopharmacol Neurosci. 2019; 17(2):222-232. doi: 10.9758/cpn.2019.17.2.222
Share
Back to top
Journal of Clinical and Basic Psychosomatics, Electronic ISSN: 2972-4414 Print ISSN: 3060-8562, Published by AccScience Publishing